Reducing early exposure to calcineurin inhibitors: The key factor for a successful renal sparing strategy

American Journal of Transplantation

Volumn 13, Issue 1, 2013, Pages 239-

  Rodriguez Peralvarez M ^a,b   Germani, G ^a   Darius, T ^c   Lerut, J ^c   Tsochatzis, E ^a   Burroughs, A K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; EVEROLIMUS; TACROLIMUS;

ACUTE GRAFT REJECTION; CHRONIC DISEASE; DRUG DOSE REDUCTION; DRUG EXPOSURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LETTER; LIVER TRANSPLANTATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION;

CALCINEURIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; SIROLIMUS;

EID: 84871836701     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04306.x     Document Type: Letter

References (4)

1. Fischer L, Klempnauer J, Beckebaum S, et al.. A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT. Am J Transplant 2012; 12: 1855-1865.
2. Ojo AO, Held PJ, Port FK, et al.. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
3. Rodriguez-Perálvarez M, Germani G, Darius T, Lerut J, Tsochatzis E, Burroughs AK,. Tacrolimus trough levels, rejection and renal impairment in liver transplantation: A systematic review and meta-analysis. Am J Transplant 2012; 12: 2797-2814.
4. Venkataramanan R, Shaw LM, Sarkozi L, et al.. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol 2001; 41: 542-551.